Additionally, CHD1 is mutated in prostate cancer [63–65] and through TAT-SF1, Merlin interacts with the U2 snRNP complex of the spliceosome, whose components are also frequently mutated in several cancer types [66]. This evidence concerns the gene CHD1 and prostate cancer.